All Blogs

Dec 14, 2022

Evaluating the Impact of Clinical Decision Support Systems (CDSS) on Health Outcomes


Dec 13, 2022

Amgen to Purchase Horizon Therapeutics; IND Clearance to Vertex’s VX-522; FDA Fast-Track Designation for Moleculin’s WP1122; Orphan Drug Designation to Brim’s WP1122; Eisai Presents Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study; UCB Announces Phase 3 Studies for Bimekizumab


Dec 12, 2022

Myotonic Dystrophy Treatment: In Search of Effective Weaponry to Kick Out Toxic RNAs Weakening Muscles


Dec 09, 2022

ASH 2022 Annual Meeting – Insights Into Major Diffuse Large B-cell Lymphoma (DLBCL) Abstract and Breakthroughs


Dec 09, 2022

Chronic Smell and Flavor Loss Treatment Market Garners Attention amid the Pandemic Chaos


Dec 08, 2022

Olympus Launches New Gynecologic Power Morcellator; Journey Biosciences Launched NaviDKD; GE Board Approves Separation of GE HealthCare; FDA Approval to Enovis’s STAR Ankle; FDA Clearance to Deep Blue Medical’s T-Line Hernia Mesh; NeuroOne Completed Feasibility Study with its OneRF Ablation System


Dec 07, 2022

Navigating the Vital Role of Bioinformatics in Biological Processes and Medicine


Dec 06, 2022

Nkarta’s Anti-CD19 Allogeneic CAR-NK Cell Therapy, NKX019; Eisai Presents Results of lecanemab for Alzheimer’s Disease; EQRx’s Aumolertinib for EGFR-Mutated NSCLC; FDA Approves Olutasidenib for IDH1-Mutated R/R AML; FDA Orphan Drug Designation to AUM302 for Neuroblastoma; X4 Pharma Announces Results for WHIM Syndrome Drug


Oct 04, 2024

Which Key Player Holds the Potential to Corner the Rheumatoid Arthritis Therapeutics Market?


Dec 02, 2022

PD-1 and PD-L1 Inhibitors: Will They Dominate Over Conventional Cancer Therapies?